Epsom and St Helier University Hospitals NHS Trust
11
2
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
9.1%
1 terminated/withdrawn out of 11 trials
50.0%
-36.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Aspirin to Target Arterial Events in Chronic Kidney Disease
Role: collaborator
Reporting of Tumour Deposits in Colorectal Cancer by Radiology and Pathology
Role: collaborator
Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.
Role: collaborator
Legacies and Futures: Measuring Roles of Resilience and Vulnerability in Pregnancy and Birth Outcomes
Role: collaborator
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
Role: collaborator
Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
Role: collaborator
Lung Nodule Imaging Biobank for Radiomics and AI Research
Role: collaborator
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
Role: lead
Metformin in Intrahepatic Cholestasis of Pregnancy
Role: lead
Women's Knowledge and Attitudes to Use of Mesh in Gynaecological Surgery
Role: lead
Metformin in Obese Non-diabetic Pregnant Women
Role: lead
All 11 trials loaded